162 related articles for article (PubMed ID: 8708759)
21. Whole-body PET/CT evaluation of tumor perfusion using generator-based 62Cu-ethylglyoxal bis(thiosemicarbazonato)copper(II): validation by direct comparison to 15O-water in metastatic renal cell carcinoma.
Fletcher JW; Logan TF; Eitel JA; Mathias CJ; Ng Y; Lacy JL; Hutchins GD; Green MA
J Nucl Med; 2015 Jan; 56(1):56-62. PubMed ID: 25525184
[TBL] [Abstract][Full Text] [Related]
22. PET of hypoxia and perfusion with 62Cu-ATSM and 62Cu-PTSM using a 62Zn/62Cu generator.
Wong TZ; Lacy JL; Petry NA; Hawk TC; Sporn TA; Dewhirst MW; Vlahovic G
AJR Am J Roentgenol; 2008 Feb; 190(2):427-32. PubMed ID: 18212229
[TBL] [Abstract][Full Text] [Related]
23. Copper-62 ATSM as a hypoxic tissue tracer in myocardial ischemia.
Takahashi N; Fujibayashi Y; Yonekura Y; Welch MJ; Waki A; Tsuchida T; Sadato N; Sugimoto K; Nakano A; Lee JD; Itoh H
Ann Nucl Med; 2001 Jun; 15(3):293-6. PubMed ID: 11545205
[TBL] [Abstract][Full Text] [Related]
24. 62Cu-PTSM and PET used for the assessment of angiotensin II-induced blood flow changes in patients with colorectal liver metastases.
Flower MA; Zweit J; Hall AD; Burke D; Davies MM; Dworkin MJ; Young HE; Mundy J; Ott RJ; McCready VR; Carnochan P; Allen-Mersh TG
Eur J Nucl Med; 2001 Jan; 28(1):99-103. PubMed ID: 11202458
[TBL] [Abstract][Full Text] [Related]
25. Effects of ischemia-reperfusion injury on myocardial single pass extraction and retention of Cu-PTSM in perfused rat hearts: comparison with 201T1 and 14C-iodoantipyrine.
Wada K; Fujibayashi Y; Taniuchi H; Tajima N; Tamaki N; Konishi J; Yokoyama A
Nucl Med Biol; 1994 May; 21(4):613-7. PubMed ID: 9234318
[TBL] [Abstract][Full Text] [Related]
26. Development of a high performance zinc-62/copper-62 radionuclide generator for positron emission tomography.
Zweit J; Goodall R; Cox M; Babich JW; Potter GA; Sharma HL; Ott RJ
Eur J Nucl Med; 1992; 19(6):418-25. PubMed ID: 1618233
[TBL] [Abstract][Full Text] [Related]
27. Correlation of Cu(PTSM) localization with regional blood flow in the heart and kidney.
Barnhart AJ; Voorhees WD; Green MA
Int J Rad Appl Instrum B; 1989; 16(7):747-8. PubMed ID: 2613532
[TBL] [Abstract][Full Text] [Related]
28. In vivo comparison of copper blood-pool agents: potential radiopharmaceuticals for use with copper-62.
Mathias CJ; Welch MJ; Green MA; Diril H; Meares CF; Gropler RJ; Bergmann SR
J Nucl Med; 1991 Mar; 32(3):475-80. PubMed ID: 2005455
[TBL] [Abstract][Full Text] [Related]
29. Tissue blood flow estimation with copper(II)-pyruvaldehyde bis (N-4-methylthiosemicarbazone) and PET.
Young H; Carnochan P; Zweit J; Babich J; Cherry S; Ott R
J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):89-91. PubMed ID: 7632775
[TBL] [Abstract][Full Text] [Related]
30. Mitochondria-selective reduction of 62Cu-pyruvaldehyde bis(N4-methylthiosemicarbazone) (62Cu-PTSM) in the murine brain; a novel radiopharmaceutical for brain positron emission tomography (PET) imaging.
Fujibayashi Y; Wada K; Taniuchi H; Yonekura Y; Konishi J; Yokoyama A
Biol Pharm Bull; 1993 Feb; 16(2):146-9. PubMed ID: 8395929
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of copper(II)-pyruvaldehyde bis (N-4-methylthiosemicarbazone) for tissue blood flow measurement using a trapped tracer model.
Young H; Carnochan P; Zweit J; Babich J; Cherry S; Ott R
Eur J Nucl Med; 1994 Apr; 21(4):336-41. PubMed ID: 8005157
[TBL] [Abstract][Full Text] [Related]
32. Measurement of regional cerebral plasma pool and hematocrit with copper-62-labeled HSA-DTS.
Okazawa H; Yonekura Y; Fujibayashi Y; Yamauchi H; Ishizu K; Nishizawa S; Magata Y; Tamaki N; Fukuyama H; Yokoyama A; Konishi J
J Nucl Med; 1996 Jul; 37(7):1080-5. PubMed ID: 8965173
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of 62Cu labeled diacetyl-bis(N4-methylthiosemicarbazone) as a hypoxic tissue tracer in patients with lung cancer.
Takahashi N; Fujibayashi Y; Yonekura Y; Welch MJ; Waki A; Tsuchida T; Sadato N; Sugimoto K; Itoh H
Ann Nucl Med; 2000 Oct; 14(5):323-8. PubMed ID: 11108159
[TBL] [Abstract][Full Text] [Related]
34. PET with 62Cu-ATSM and 62Cu-PTSM is a useful imaging tool for hypoxia and perfusion in pulmonary lesions.
Zhang T; Das SK; Fels DR; Hansen KS; Wong TZ; Dewhirst MW; Vlahovic G
AJR Am J Roentgenol; 2013 Nov; 201(5):W698-706. PubMed ID: 24147499
[TBL] [Abstract][Full Text] [Related]
35. Hyperfixation of copper-62-PTSM in rat brain after transient global ischemia.
Taniuchi H; Fujibayashi Y; Yonekura Y; Konishi J; Yokoyama A
J Nucl Med; 1997 Jul; 38(7):1130-4. PubMed ID: 9225805
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of copper-labeled bifunctional chelate-albumin conjugates for blood pool imaging.
Anderson CJ; Rocque PA; Weinheimer CJ; Welch MJ
Nucl Med Biol; 1993 May; 20(4):461-7. PubMed ID: 8504288
[TBL] [Abstract][Full Text] [Related]
37. Assessment of myocardial perfusion by positron emission tomography.
Schwaiger M; Muzik O
Am J Cardiol; 1991 May; 67(14):35D-43D. PubMed ID: 2035433
[TBL] [Abstract][Full Text] [Related]
38. Tissue perfusion of copper-62-PTSM: relevance of studies in animal models as predictors of clinical radiopharmaceutical performance.
Fritzberg AR
J Nucl Med; 1995 Aug; 36(8):1456-7. PubMed ID: 7629594
[No Abstract] [Full Text] [Related]
39. Concordance of nutritive myocardial perfusion reserve and flow velocity reserve in conductance vessels in patients with chest pain with angiographically normal coronary arteries.
Shelton ME; Senneff MJ; Ludbrook PA; Sobel BE; Bergmann SR
J Nucl Med; 1993 May; 34(5):717-22. PubMed ID: 8478702
[TBL] [Abstract][Full Text] [Related]
40. Effect of caffeine intake on myocardial hyperemic flow induced by adenosine triphosphate and dipyridamole.
Kubo S; Tadamura E; Toyoda H; Mamede M; Yamamuro M; Magata Y; Mukai T; Kitano H; Tamaki N; Konishi J
J Nucl Med; 2004 May; 45(5):730-8. PubMed ID: 15136619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
